Unexplained weight loss (UWL), defined as a decrease of 5% or more in body weight over a period of 6-12 months without a known cause, is a challenging clinical scenario. It can be indicative of a myriad of underlying conditions, ranging from malignancies to chronic infections, and therefore demands a comprehensive, systematic approach.
The first step in the assessment of UWL is a thorough history and physical examination. Special attention should be given to dietary intake, physical activity, psychological status, and medication use. The presence of symptoms like fever, pain, or changes in bowel habits might suggest specific etiologies.
Basic laboratory investigations, including complete blood count, renal and liver function tests, thyroid function tests, and markers of inflammation, are usually conducted in all patients. Imaging studies, such as chest X-ray or abdominal ultrasound, may be considered based on the patient's symptoms and risk factors. More targeted investigations, like endoscopy or biopsy, may be needed if initial tests are inconclusive.
Management strategies for UWL depend on the underlying cause. In some cases, symptom management and nutritional support may be all that's required. In others, specific treatments for identified diseases are necessary. It's crucial to involve a multidisciplinary team, including dietitians and psychologists, in the patient's care.
The approach to UWL in clinical practice requires careful evaluation, a high index of suspicion, and a patient-centered approach. By combining a thorough history, physical examination, and appropriate investigations, clinicians can effectively diagnose and manage the underlying causes of UWL. Continued research is needed to improve our understanding and management of this complex clinical scenario.
1.
Global warming could be driving up women's cancer risk, find researchers
2.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
3.
Survey shows cancer anxiety has impact well beyond the individual diagnosed
4.
MRI can save rectal cancer patients from surgery, study suggests
5.
Glioma Outcomes Shaped by Subtype More Than Tx Sequence
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Practical Breakthroughs in Oncology Across Clinical Settings
3.
Gynecologic Oncology: Advances, Education, and Clinical Excellence
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
RNA-Targeting Chimeras in Cancer: Mechanisms, Clinical Advances, and Future Directions
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Cancer Care: From Awareness to Recovery
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation